Perry-duxbury, Megan, Lomas, James, Asaria, Miqdad ORCID: 0000-0002-3538-4417 and Van Baal, Pieter (2022) The relevance of including future healthcare costs in cost-effectiveness threshold calculations for the UK NHS. PharmacoEconomics, 40 (2). 233 - 239. ISSN 1170-7690
Text (Perry-Duxbury2021_Article_TheRelevanceOfIncludingFutureH)
- Published Version
Available under License Creative Commons Attribution Non-commercial. Download (760kB) |
Abstract
Background and Objective The supply-side threshold for the UK National Health Service has been empirically estimated as the marginal returns to healthcare spending on health outcomes. These estimates implicitly exclude future healthcare costs, which is inconsistent with the objective of making the most efficient use of healthcare resources. This paper illustrates how empirical estimates of the threshold within healthcare can be adjusted to account for future healthcare costs. Methods Using cause-deleted life tables and previous work on future costs in England and Wales, we illustrate how such estimates can be adjusted. Results While the effect of including future healthcare costs can have substantial effects on incremental cost-effectiveness ratios of specific life-extending interventions, we find that including future costs has relatively little impact (an increase of £743 per quality-adjusted life-year) on the threshold estimate. Conclusions For some life-extending interventions the impact of including future costs on whether an intervention is deemed cost effective may be considerable.
Item Type: | Article |
---|---|
Official URL: | https://www.springer.com/journal/40273 |
Additional Information: | © 2021 The Authors |
Divisions: | LSE Health |
Subjects: | R Medicine > RA Public aspects of medicine H Social Sciences > HJ Public Finance |
Date Deposited: | 26 Oct 2021 13:15 |
Last Modified: | 16 Nov 2024 06:18 |
URI: | http://eprints.lse.ac.uk/id/eprint/112503 |
Actions (login required)
View Item |